Literature DB >> 20610113

Customized transepithelial no-touch ablation as therapeutic option.

Urs M Thomann, Isaak Schipper.   

Abstract

Mesh：

Year:  2010        PMID： 20610113     DOI： 10.1016/j.jcrs.2010.04.023

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN： 0886-3350            Impact factor:   3.351


× No keyword cloud information.
  3 in total

1.  Single-step transepithelial ASLA (SCHWIND) with mitomycin-C for the correction of high myopia: long term follow-up.

Authors:  Ioannis M Aslanides; Panagiotis N Georgoudis; Vasilis D Selimis; Achyut N Mukherjee
Journal:  Clin Ophthalmol       Date:  2014-12-30

2.  5-year efficacy of all surface laser ablation with cross-linking (ASLA-XTRA) for the treatment of myopia.

Authors:  Ioannis M Aslanides; Farhad Hafezi; Shihao Chen; Hatch Mukherjee; Vasileios Selimis; Ilias Maragkos; Nanji Lu; George Kymionis
Journal:  Eye Vis (Lond)       Date:  2020-06-11

3.  Fine tuning of the default depth and rate of ablation of the epithelium in customized trans-epithelial one-step superficial refractive excimer laser ablation.

Authors:  Michael Goggin; Peter Stewart; Vikija Andersons; Giuseppe Criscenti
Journal:  Eye Vis (Lond)       Date:  2019-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.